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Background: Effective prevention against cancers depends heavily on sustained individual efforts practicing
protective behaviors and avoiding risk factors in a complex sociocultural context, which requires continuous and
personalized supports. Contemporary prevention relies primarily on strategies targeting general population with
limited attention being paid to individualized approaches. This study tests a novel package called, in acronym of
core intervention components, eCROPS-CA that leverages protective behaviors against over 80% leading cancers
among high risk individuals via continuous and tailored counseling by village doctors.
Methods/Design: The study utilizes a quesi-RCT design involving 4320 high risk individuals selected, via rapid and
detailed risk assessments, from about 72,000 farmers aged 35+ in 36 administrative villages randomized into equal
intervention and delayed intervention arms. The intervention arm receives baseline and semiannual follow up evaluations
plus eCROPS-CA for 5 years; while the control arm, only the baseline and follow-up evaluations for the first 5 years and
eCROPS-CA starting from the 6th year if the intervention is proved effective. eCROPS-CA comprises electronic supports
and supervision (e), counseling cancer prevention (C), recipe for objective behaviors (R), operational toolkit (O),
performance-based incentives (P), and screening and assessment (S). Evaluation measures include: incidence and stage of
the leading cancers, cancer-related knowledge, attitudes and practices; easy biophysical indicators (e.g., body mass index,
blood pressure); intervention compliance, acceptance of the package.
Discussion: The prevention package incorporates key success factors in a synergetic way toward cost-effectiveness and
long-term sustainability. It targets a set rather than any single cancer; choses village doctors as key solution to
the widespread lack of professional manpower in implementing personalized and thus relatively sophisticated
prevention; adopts real-time monitoring in reaching continuous improvement; utilizes smart web aids to enable
prioritizing complex determinants of objective behaviors, linking counseling sessions happened at different time
points and hence delivering highly coordinated prevention; uses 2-stage risk assessment models in identifying
high risk individuals so as to focus on the most needed; applies standardized operation procedures in simplifying
and smoothing behavior intervention yet ensuring delivery of essential steps and key elements.
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Cancers have long been a major cause of human death
and diseases-adjusted life year (DAILY) loss [1]. In 2000,
new cancer cases and deaths accounted for 10.1 and 6.2
million respectively worldwide. The same figures in-
creased to 10.86 and 6.73 million by 2002 [2]. In 2005,
over 7.6 million people died to cancer accounting for
13% of total deaths [3]. Predicted cases and deaths will
reach about 15 and 10 million by 2020 [4]. The most
common cancers in terms of incidence rate were lung
cancer, breast cancer and colorectal cancer and, in terms
of mortality rate, lung cancer, stomach cancer and liver
cancer [5]. The situation of cancer in China is also most
serious. According to China national cancer registration
statistics in 2009, standardized cancer incidence rate was
191.72 per 100 thousand and mortality rate, 115.65 [6].
Cumulative incidence rate (age 0–74) in China added up
to 21.99% and total incidence cases, over 2.2 million a
year [7]. WHO data showed that malignant tumors
worldwide took up 5% of total burden caused by all dis-
eases in 2005 [8]. More recent investigations revealed
that cancers were the first death cause in cities [9]. In
2006, direct and indirect economic loss due to the dis-
ease was 11.32 and 6.00 billion USD respectively repre-
senting 4.67% of total medical cost [10].
The harms of cancers to human health can be attrib-
uted to prevention, diagnosis and treatment defects.
Accordingly, control strategies against the diseases div-
ide into proactive prevention, early detection and appro-
priate treatment. Tremendous efforts have been invested
on clinical diagnosis and treatment for a long time,
but associated survival prolongation is rather limited
[11-16]. As a result, prevention and early detection are
gaining recognition. However, contemporary approaches
focus primarily on public education (e.g., disseminating
prevention information via various mass media) [17-25],
screening service, and drug prevention (e.g., use of folic
acid or tamoxifen) and treatment of precancerous condi-
tions (e.g., polyps, Helicobacter pylori infection) [26-33].
Public education is most cost-effective for communicat-
ing general knowledge, but its benefit is restricted largely
by the fact that there exists a huge disparity between
knowledge and behavior [27,28]. Similarly, although a
large number of researches have revealed that screening
for high-risk groups and some drugs and treatment pre-
vention are highly cost-effective under research condi-
tions, these measures are seldom in use in routine
practices of cancer prevention and control [28]; even
used, the effectiveness often turned out to be far less
from expected [34-40].
Although the huge gap between the actual application
of proven preventions and expectations may be attrib-
uted to a variety of reasons, lacking personalized behav-
ior promotion may have plaid an important role [41].Most cancer prevention measures can only work when
the target individuals themselves take action. For ex-
ample, cancer prevention knowledge communicated via
mass media needs to be understood, accepted and finally
translated into action by intended audiences. Likewise,
screening for cancers regularly, treating precancerous le-
sions and others, all depend heavily on the acceptance
and cooperation of the individuals in need of these ser-
vices. General or non-tailored education and service pro-
motion often fails in initiating or maintaining desired
prevention practices due to extreme complexity of the
factor system determining these behaviors. On the one
hand, the nexus of complex factors makes it hard for or-
dinary residents to perceive true relationships between
prevention measures and cancer incidence and harms.
This greatly weakens the motivation for implementing the
measures. On the other, effectively changing the outcomes
of a complicated behavior determinant system requires in-
tegrating multiple measures in a synergetic way. This is to
the disadvantage of general “education” and often beyond
the ability of ordinary people especially old rural farmers
with over 61.8% of illiteracy [42]. Similar challenges also
perpetuate diabetes-related behavior intervention. In order
to promote sustainable lifestyle modifications preventing
progression from pre-diabetes to diabetes, we developed
an intervention package called eCROPS and tested it in
rural Luan, Anhui, China with encouraging early findings
[43]. This study tires to adapt eCROPS to suit cancer be-
havior intervention and evaluate its efficacy. This new
intervention package (further referred to as eCROPS-CA)
targets at multi-types of cancers at the same time and
stresses reliance on village doctors, integration of cancer
prevention with routine medical service, incorporation of
multiple strategies in motivating the involved, theory-
guided standardization and assessment-based tailoring,
and low cost and sustainability.
Although there are a few articles documenting behavior
intervention against single type cancer using simple mea-
sures (e.g., application of telephone or emails in containing
tobacco and alcohol consumption after intestinal polyps
resection [44-46]), researches attempting cancer preven-
tion in a systematic way like this are limited. China has a
long history of separated systems for disease treatment
(medical system) and prevention (CDC system) [47]. The
CDC system is founded by the government and launches
free cancer preventions (primarily mass media education
and case registry); while the medical system depends
almost solely on fee for service and provides cancer
screening, diagnosis and treatment at patients’ expenses.
Although village doctors belong to the medical system,
they are not qualified to deliver neither cancer screening
nor diagnosis and treatment. So they seldom involve in
cancer-related services. The large number of village doc-
tors (over one million) provides enormous potential for
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cultural role of them provides necessary professional
legitimacy. Chinese people hold strong beliefs that doctors
(including village doctors) are respectful and trustworthy
because they save lives and that human body is too com-
plex for ordinary people to fully understand and patients
should take their doctors’ advice since they are educated
and experienced in dealing with complex health problems
[49]. Village doctors enjoy easy access to farmers and
knew the patients’ language and level of understanding;
while their professional knowledge and experience can
greatly facilitate their involvement in cancer intervention
and a minimal training can produce highly effective cancer
interventionists. More importantly, most cancer prevention
service can be arranged to coincide routine medical care
which provides a unique teaching moment when health is
valued and help from doctors is most needed [50].
Methods/Design
Study design
The study utilizes, after one year and a half piloting, a
quesi-RCT (randomized controlled trial) design and in-
volves 4320 high risk individuals selected, via rapid risk
assessments (RRA) and detailed risk assessments (DRA),
from about 72,000 farmers aged 35 or older in 36 ad-
ministrative villages randomized into equal intervention
and delayed intervention arms. The intervention arm re-




























Figure 1 Study subject sampling and randomization.plus eCROPS-CA for 5 years; while the control arm,
only the same baseline and follow up evaluations for the
first 5 years and eCROPS-CA starting from year 6 if the
intervention is proved effective.
Study aim
The study aims at demonstrating that eCROPS-CA is ef-
fective in preventing leading cancers and high risk individ-
uals in the intervention arm will, compared to those in the
delayed intervention condition, show a lower incidence of
cancers, improved cancer-related KAP (knowledge, atti-
tudes and practices) and easy-biophysical indicators, and
increased use of cancer prevention service. A secondary
objective is to establish a sustainable mechanism, in which
participating village doctors maintain continuous momen-
tum integrating cancer prevention with routine medical
service ever since initiation of this project in resource-
poor rural China.
Study sample
Selection and randomization of villages
The study involves 36 administrative villages sampled
through 3 stages (Figure 1). Stage 1 classifies all the
counties in Anhui province into southern, northern and
middle areas. Stage 2 randomly selects 3 counties from
each of the areas. Stage 3 draws 4 villages with the lar-
gest number of famers from each of the counties and
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arms). All delayed intervention villages within half-day
walking distance from any intervention one are re-
sampled for avoiding cross contamination. The random-
izing proceeds in two steps: each of the 9 county CDCs
(centers for disease control and prevention) provides a
roster and map of administrate villages with over 4000
resident farmers within its jurisdiction; the eCROPS-CA
Technique Group from Anhui Medical University per-
forms randomized selection and grouping.Eligibility criteria of participants
The study recruits both village doctors and their pa-
tients. All the accredited village doctors working for
the clinics of the selected villages are encouraged to
participate. Inclusion criteria of patients include men
and women who: are 35 years or older; live in the se-
lected villages for over 6 months per year (a large part
of rural farmers migrate to cities for temporary jobs
every year); meet the cut point score of RRA (≥ the
70th percentile of RRA score) and DRA (≥ the 80th per-
centile of DRA score). Farmers who have already diag-
nosed with cancer(s) or mental illness or serious illness
or disability are excluded.Sample size
The study sample size derives from the key assumption
expected to check that eCROPS-CA may prevent the
leading cancers including stomach, trachea/bronchus/
lung, esophagus, liver, colon/rectum/anus, breast, cer-
vix, pancreas, and nasopharynx cancers. Based on our
previous research, for a village with over 4000 farmers,
about 2000 aged 35+ seek service from the village clinic
within one year. The rapid assessment identifies 30% of
them (i.e., 600) as tentative risk famers (TRFs) and the
detailed assessment in turn, 20% of the TRFs as final
risk famers (FRFs). In this way, about 72000 famers
from the 36 villages will receive RRA, 21600 will go a
step further into DRA and a total of 4320, into inter-
vention and control groups. Our previous small scale
investigation observed a total of 34 cases of the 9-cancers
out of 296 FRFs in 3 years (872 person-years in total). So
the annual incidence rate and the 3 year cumulative inci-
dence rate were 3.90% and 12.20% separately. Given these
and suppose: intervention has a moderate effect (20% re-
duction) in the cumulative incidence rate of the 9-cancers
in 5 years; significance level (alpha) is set at 0.05 to avoid a
Type I error, and power (1–beta), at 95% to avoid a Type
II error; c) 5-year follow up attrition is 20%. Therefore,
4320 FRFs should have over 95% chance of detecting sig-
nificant difference in 5-year cumulative incidence rate of
the cancers.Intervention
Over view of intervention content and flow In
addition to existing curative and preventive services, the
intervention arm implements eCROPS-CA, where CA
stands for cancer while letters in the acronym eCROPS,
electronic supports and supervision (e), counseling be-
havior prevention (C), recipe for objective behaviors (R),
operational toolkit (O), performance-based incentives
(P), screening and assessment (S) respectively. These
components are subject to continuous refinement in ac-
cordance with the findings from the semiannual evalua-
tions to be described later especially feedbacks from
participating village doctors and farmers. Figure 2 sum-
marizes the components of the intervention package
and their relationships. Figure 3 depicts the main proce-
dures of the intervention, the logic flows among these
procedures and how they fit with traditional medical
service at village clinics. While the following subsec-
tions provides item-by-item briefings of eCROPS-CA
components.
Counseling cancer prevention (C) Counseling behavior
prevention (C) divides into 3 categories, i.e., risk assess-
ment promotion, objective behavior initiation and object-
ive behavior reinforcement. Risk assessment promotion
applies to farmers scored higher than the 70th percentile
score of RRA and aims at promoting acceptance of DRA.
Counseling behavior initiation happens to farmers who
have scored higher than the 80th percentile score of the
DRA yet not experienced the project-designed behavior
intervention and tries to raise their awareness of elevated
cancer risks and urges them to take action reducing the
risks. It proceeds in 5 steps (blue rectangles in Figure 3):
alerting risks and harms; setting objective behaviors; dis-
cussing efficacy and benefits; anticipating barriers and
problems; providing assistance and supports. Here, object-
ive behavior refers to desired behaviors (such as eating
more vegetables and regular self-examination) conducive
to cancer prevention. Counseling behavior reinforcement
targets follow-up farmers who have received initial
behavior change counseling and focuses on reinforcing be-
havior improvement and solving problems encountered in
implementing the changes. It also consists of 5 steps (pink
rectangles in Figure 3): reviewing behavior changes; en-
couraging improvement; identifying problems; selecting
problems; solving problems. All counseling sessions uti-
lizes standard operation procedures (SOPs) to ensure de-
livery of key elements, though the counselor village
doctors are encouraged to make the best use of their own
experiences. Development of the SOPs employs similar
steps, theories and methods we used in deriving the SOPs
for diabetes prevention [51,52].
Behavior counseling happens at a monthly (in the first
year), bimonthly (in the second year) and quarterly base
Figure 2 Intervention components and their relationships.
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a number of considerations: the counseling need to cover
a total of 7 categories of objective behaviors (Figure 2); a
typical village doctor serves about 15 patients a day and
has enough spare time to deliver counseling; most village
clinics locate within 15 minute walking from the farmers
and amid their way for going shopping, sending children
to schools etc.; walking to and from village clinics may also
be viewed as a way to promote additional physical activ-
ities, one of the planned objective behaviors.Recipe for objective behaviors (R) Recipe of objective
behaviors (R) consists of a complete list of the behaviors
this study tries to make its target farmers to practice and
rules/tips for doing so in forms of education leaflets and
webpages. The list comprises 7 categories: improving diet
and nutrition (e.g., more vegetables, less cured foods);
increasing physical activities (e.g., work, housework and
leisure-time activities); reducing risk behaviors (e.g., smok-
ing, unprotected sex); regulating mood and feeling (e.g.,
depression, anxiety); seeking help and services (e.g., cancer
screening, treatment for pre-cancerous conditions); avoid-
ing environmental carcinogens (e.g., benzene, arsenic); in-
volving friends and relatives (e.g., spouse or colleagues in
exercises). For each of these objective behaviors, the recipe
provides bulleted items telling: why one should practice
the behavior; how to initiate and maintain the behavior;
what problems may encounter in implementing the be-
havior; how to solve the problems.Operational toolkit (O) Operational toolkit (O) gears
with a series of operational tools including: “reference
table/lists” of cross-links between cancers and risk factors,
contacts of related referral services etc.; “worksheets” for
planning diet, physical activities, follow up visits etc.; “easy
calculators” for estimating body mass index (BMI), diet
calorie intake or glycemic index, activity calorie consump-
tion etc.; and “visual-aids” for demonstrating composition
of risk factors and trends in estimated cancer risk score,
BMI,blood pressure, plasma glucose etc. All these tools
are easily accessible by participating doctors and farmers
via the project website at any time (Figure 4).Performance-based incentives (P) Performance-based
incentives (P) aim at generating adequate momentum
for village doctors to deliver designed intervention
through financial reimbursement, prevention require-
ment, continuing education credit, and membership of
Integrated Service Network. More specifically, participat-
ing doctors meeting set performance standard get reim-
bursed at about $3.5 per case-year; involvement in the
cancer prevention satisfies a policy, newly issued by the
local health authorities due to the project, mandating
that all practicing village doctors must deliver a minimum
of prevention service so as to qualify future license re-
newal; completion of the project training and case report-
ing and analysis entails awarding of continuing education
credits required by annual performance appraisal. In





























































Figure 3 Logic flow of designed cancer prevention service.
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enjoys: free access to periodical circulation of a Newsletter
and web-based forum for sharing cases and experiences
maintained by members of the Network; technical assist-
ance from higher level network members including mem-
bers from prefecture and province level hospitals; dual
referral privilege within the Network.
Screening and assessment (S) Screening and assess-
ment (S) utilizes a two stage strategy, i.e., RRA (10 to
15 minutes) followed by DRA (20 to 35 minutes), and
serves 3-fold purposes: to identify high-risk farmers and
thus deliver focused intervention; to inform personalized
and outcome-oriented behavior intervention; to enable
intervention quality monitoring and supervision. RRA
covers all visiting patients aged 35+ who have not re-
ceived the same assessment in the last two years. It so-
licits information about risks of developing cancers for
individual patients using a web-based structured ques-
tionnaire (Additional file 1, Part A) and automatically
produces, via the web-based system, a risk score for thepatient. If the RRA score is higher than the preset RRA
cut point mentioned earlier, a DRA follows which ex-
pands the scope and detail of the information collected
via the RRA using again a web-based structured instru-
ment (Additional file 1, Part B). DRA also automatically
generates a risk score for each patient and if this DRA
score is higher than the preset DRA cut point, the pa-
tient is eligible to receive further intervention and evalu-
ate on. Calculation of both the RRA and DRA risk
scores utilizes a two-stage weighing system (Additional
file 1, Part C).
Electronic supports and supervision (e) Electronic
supports and supervision (e) adapt from the smart web-
aid we developed for preventing diabetes [52] and
consists of user-friendly education and learning assist-
ance (ELA, e1), high-risk individual management system
(HIMS, e2), and effectiveness and quality monitoring
(EQM, e3). The HIMS provides doctors with a whole set
of helps ranging from maintaining a dataset of high-risk
farmers, scheduling and reminding (via land or cell-
a) Diet analyzer and planner(case 001)
b) Cancer risk profile(Top 5 cancers, case 001) 
Figure 4 Sample applications of project operational toolkit viewed using a smart phone.
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vidual performance and intervention history, to facilitat-
ing (via built-in standard operating procedures) delivery
of intervention counseling etc. The ELA for village doc-
tors comprises: web-based tutorial on implementing the
project prevention in both video and textile formats; typ-
ical case studies in which participating village doctors
are requested to record and post at least 1 bottom case
(in terms of compliance with planned behavior changes)
bimonthly on a Web-Forum and then experts and other
village doctors share experiences coping with similar
cases; video and pictorial materials about cancer and its
prevention suitable for displaying at village clinics for at-
tending high-risk patients. The EQM assists project
managers to: solicit relevant data for monitoring cancer
behavior intervention; identify deviation from planned
deliverables; and feedback monitoring findings.Control
The control arm maintains existing curative and pre-
ventive services without adding any prevention compo-
nent included in eCROPS-CA except for RRA and DRA.Study and data integrity
The study design follows the CONSORT (Consolidated
Standards of Reporting Trials) statement [53].
Measures
The study uses 5 types of outcome and process measures
to assess intervention efficacy and sustainability, i.e., diag-
nosed type and stage of cancers, cancer-related KAP
(knowledge, attitudes and practices), easy biophysical
indicators, intervention compliance and acceptance of
eCROPS-CA (Table 1). In addition, the study also collects
related social demographic variables e.g., age, gender,
ethnicity, migration patterns, marital status, education.
Evaluation time points
Evaluation of the intervention package happens at baseline
and semiannually thereafter. Each round of field data col-
lection lasts for one week scheduled at the week before
doctor training and the last week of the 6th, 12th, 18th, 24th,
30th, 36th, 42th, 48th, 54th, and 60th month after the baseline
respectively. Both intervention and control arms receive
identical evaluation using same questionnaire, same field
data collectors and same assessment time points.
Table 1 Main outcome measures for assessing intervention efficacy
Domain of measures Specific indicators
A) Cases and stages of cancers diagnosed Cases of the 9 cancers newly diagnosed from last assessment; date and evidence of diagnosis;
stage of the cancers at diagnosis.
B) Related knowledge, attitudes and practices Knowledge about susceptibility and seriousness of cancer; knowledge about effectiveness of
practicing each of the objective behaviors; knowledge about benefits of practicing each of the
objective behaviors; knowledge about barriers to practicing each of the objective behaviors;
knowledge about strategies/techniques for coping with each of the barriers to practicing
each of the objective behaviors; practice of each of the objective behaviors.
C) Easy biophysical indicators Body height; body weight; waist circumstance; hip circumstance; systolic/diastolic blood pressure,
fasting plasma glucose etc.
D) Intervention compliance Proportion of eligible patients who complete detailed risk assessment; proportion of eligible
patients who attend at least 10 counseling sessions in the first year of the intervention and at
least 5 sessions in each of the following years; proportion of village clinic doctors who complete
at least 90% of the counseling sessions assigned.
E) Acceptance of eCROPS-CA Acceptance, beliefs and comments about the eCROPS-CA as a whole and specific components voiced
by key informants, e.g., participating village doctors, farmers and project managers and supervisors.
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Analysis of quantitative data proceeds in 3 steps. Initial ana-
lysis centers on descriptive summaries intended to examine
major deliverables and patterns of the various measure-
ments (Table 1 and Figure 5) and check for normality of
the continuous variables. Necessary transformations are ex-
plored and selected, if necessary, to induce approximateFigure 5 Sample outcome measures between intervention and contro
blue lines, delayed intervention arm).normality. The next step estimates, using two-sided test of
the null hypothesis, the power of differences between the
intervention and delayed intervention groups and between
different time points in terms of the outcome measures.
Considering the possibility that the prevention package
may cause earlier cancer diagnosis in the intervention than
in the delayed arm and thus results in reduced difference inl arms (Red lines represent measures for intervention arm and
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composition of cancer stages parallels comparison in cancer
incidence rate between the two groups. The last step ex-
plores multivariate models, e.g., regression models be-
tween: cancer occurrence and various factors assessed via
RRA and DRA; objective behaviors and knowledge, atti-
tudes, self-efficacies, prevention services etc.; prevention
service compliance and cancer risk scores, age, gender,
education, service quality etc. Analysis of qualitative inter-
views with key informants (e.g., village doctors, farmers,
intervention supervisors, project managers) adopts similar
perspectives and methods as that used in one of our previ-
ous studies [52].
Ethical considerations
The study involves recruitment, intervention and as-
sessment of patients and village doctors. So it adheres
to rigorous human subject protection principles. The
study protocol had been reviewed and approved by the
Biomedical Ethics Committee of Anhui Medical University
(reference number: 20140271). Participation of patients
and doctors are voluntary. And written informed consent
is sought from all participants.
Discussion
The cancer prevention package (eCROPS-CA) this study
tries to test and refine has several important features.
First, eCROPS-CA incorporates key success factors in a
synergetic way toward cost-effectiveness and long-term
sustainability and targets at a set rather than a single
type of cancers. Multiple types of cancers pose problems
for interpreting the ultimate outcome (i.e., cancer inci-
dence reduction) of the intervention since, for instance,
avoidance of same cases of breast cancer and lung can-
cer may have different meanings. However, most cancers
share similar causes. For example, inadequate intake of
vegetables is not only linked with gastric cancer but also
colorectal cancer, breast cancer, liver cancer and lung
cancer etc. [54,55]. This suggests that increasing vegetable
intake may prevent a number of cancers and intervention
packages against multiple cancers may prove to be more
cost-effective than that focusing on a single cancer. Simi-
larly, comprehensive approaches make it hard to distin-
guish the effects of specific components within a package
and thus selecting and combining elements into a working
whole becomes vital yet challenging. In order to properly
tackle this challenge, eCROPS-CA adopts soft systems
thinking which originates from software development and
views all elements in an interactive and holistic way [56].
More specifically, eCROPS-CA first sets an ultimate goal
of effective, low cost and sustainable interventions against
common cancers and then identifies key success factors
for reaching this end, devices necessary intervention
components satisfying all these factors, and finally formsa practical whole. This development strategy should en-
sure that the whole intervention package is goal-oriented
and each component included has clear and important
contributions to the ultimate goal.
Second, eCROPS-CA adopts real-time effectiveness and
quality monitoring in leveraging continuous improvement.
Here, “real-time” means that the majority of data required
by the monitoring derive from ad hoc records of routine
prevention rather than from separate data reporting or col-
lection. For example, during counseling sessions, the smart
web aid always proposes step-wise topics for discussion,
each of which follows a checkbox list that enables the
counselor doctor to record essential items about what the
counselee patient has already know or done. And only
when the doctor has clicked all the required checkboxes,
can he/she proceed with the next step. This real-time re-
coding not only saves costs but also enhances accuracy of
data collection. More importantly, although managerial
monitoring relies heavily on real-time data, the primary
purpose of all these recordings is to help the village doctors
to improve their prevention service and performance. Tak-
ing the above example again, the checkboxes are designed
mainly for branching and informing next step counseling
rather than managerial monitoring. This reduces potential
conflict of interests that perpetuates most self-report-based
project monitoring since the benefits (e.g., better tailored
service, earlier detection and correction of weaknesses)
over-weight the dis-benefits (e.g., temporary or partial re-
duction in performance assessment) for maintaining high
data collection fidelity. In addition, the monitoring stresses
easy biophysical indicators (e.g., BMI, blood pressure,
plasma glucose) which incur almost no pain and the least
cost for both service providers and receivers and all of
these indicators are closely linked to the health of high risk
individuals on the one hand and the performance of the
village doctors on the other. This clear relationship makes
the monitoring most convincing for all stakeholders.
Third, eCROPS-CA utilizes powerful recording, re-
trieving and processing abilities of computer systems to
enable prioritizing complex determinants of objective
behaviors, linking counseling sessions happened at dif-
ferent time points and hence delivering highly coordi-
nated prevention services. Although computers and
internet are available at most village clinics in Anhui and
throughout China and most village doctors have elemen-
tary computer literacy [57], there are considerable fears
about the ability of village doctors in rural China to use
computerized systems. Our preliminary researches sug-
gest that electronic applications are both acceptable and
manageable to doctors even in resource-poor areas
[43,52]. Given the user-friendly education and learning
assistance, all the village doctors learned to use the sys-
tem at a one day orientation workshop. Then, after 2 to
4 weeks of self-practice, encouragement, and problem
Chai et al. BMC Cancer  (2015) 15:233 Page 10 of 11inquiring and answering, most village doctors became
confident users. By examining this protocol, one can
easily find that eCROPS-CA is almost infeasible without
the “e” component. If proved effective, this study should
inform leveraging electronic supports in exploring new
cancer prevention models and techniques.
Other characteristics of eCROPS-CA include: it uses
stage-wise risk assessment models in identifying high
risk individuals so as to greatly narrow down the scale of
intervention and focus scarce resources on the most
needed; it applies standardized operation procedures
(SOPs) derived from proven theories (e.g., health belief
model, motivational interviewing) and best practices in
simplifying and smoothing behavior intervention yet en-
suring delivery of essential steps and key success ele-
ments; it employs consecutive assessment and feedbacks
in tailoring interventions to individual’s dynamic risk
status and influence factors. These will be further ad-
dressed separately.
Additional file
Additional file 1: Detailed risk assessment instrument and scoring
systems.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JChai and XS contributed equally in conceiving this project, facilitating
protocol and SOPs development, and drafting this manuscript. RF and
JCheng designed the RRA/DRA instruments and evaluation measures. HL, TZ
and RS developed the web aid. KL and YS lead the development of
performance-based incentives. YC, ZZ and SJ facilitated project implementation.
DW provided expertise for overall design of the study, and revised and finalized
the manuscript. All authors read and approved the final manuscript.
Authors’ information
Jing Chai and Xingrong Shen are equal first authors.
Acknowledgements
Development of the primitive protocol was supported by the Natural
Science Foundation of China (grant number: 81172201). Refinement and
implementation of the protocol is lead and supported by Collaboration
Center for Cancer Control of Anhui Medical University, Anhui and Luan
Center for Diseases Control and Prevention.
Author details
1School of Health Service Management, Anhui Medical University, Hefei,
Anhui, China. 2Department of Literature Review and Analysis, Library of
Anhui Medical University, Hefei, Anhui, China. 3Anhui Center for Disease
Control and Prevention, Hefei, Anhui, China. 4Luan Center for Disease Control
and Prevention, Luan, Anhui, China. 5Collaboration Center for Cancer Control,
First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Received: 29 May 2014 Accepted: 25 March 2015
References
1. Ma X, Yu H. Global burden of cancer. Yale J Biol Med. 2006;79(3–4):85–94.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden:
GLOBOACN 2000. Int J Cancer. 2001;94(2):153–6.3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer
J Clin. 2005;55(25):74–108.
4. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol.
2001;2(9):533–43.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
2010;127:2893–917.
6. Zhang SW, Lei ZL, Li GL, Zou XN, Zhao P, Chen WQ. A report of Cancer
Incidence and Mortality from 34 Cancer Registries in China (in Chinese),
2006. China Cancer. 2010;19(6):356–65.
7. China Ministry of Health. China Annual Health Statistics. China Union
Medical University Press; 2007.
8. World Health Organization. World Health Statistics. Geneva: WHO; 2006.
9. China Ministry of Health. China Third National Death Cause Survey. Beijing:
China Union Medical University Press; 2008.
10. Wei QL. Malignant disease burden research. MD thesis. Xiamen: Xiamen
University; 2009.
11. Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, et al.
PARAMOUNT: Final overall survival results of the phase III study of
maintenance pemetrexed versus placebo immediately after induction
treatment with pemetrexed plus cisplatin for advanced nonsquamous
non-small-cell lung cancer. J Clin Oncol. 2013;31(23):2895–902.
12. Van Cutsem E, Tabernero J, Lakomy R, Prenen H, Prausová J, Macarulla T,
et al. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan
improves survival in a phase III randomized trial in patients with metastatic
colorectal cancer previously treated with an oxaliplatin-based regimen.
J Clin Oncol. 2012;30(28):3499–506.
13. Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, et al. COU-AA-
301 Investigators: Abiraterone acetate for treatment of metastatic castration-
resistant prostate cancer: final overall survival analysis of the COU-AA-301
randomised, double-blind, lacebo-controlled phase 3 study. Lancet Oncol.
2012;13(10):983–92.
14. Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, et al. Overall
survival improvement in patients with lung cancer and bone metastases
treated with denosumab versus zoledronic acid: subgroup analysis from a
randomized phase 3 study. J Thorac Oncol. 2012;7(12):1823–9.
15. Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, et al.
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment
for metastatic colorectal cancer: updated analysis of overall survival
according to tumor KRAS and BRAF mutation status. J Clin Oncol.
2011;29(15):2011–9.
16. Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, et al.
Improved survival trends in platinum-resistant patients with advanced
ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/
platinum chemotherapy: the impact of novel agents. Oncology.
2013;84(3):158–65.
17. Yi M, Park EY. Effects of breast health education conducted by trained
breast cancer survivors. J Adv Nurs. 2012;68(5):1100–10.
18. Bebis H, Reis N, Yavan T, Bayrak D, Unal A, Bodur S. Effect of health
education about cervical cancer and papanicolaou testing on the behavior,
knowledge, and beliefs of Turkish women. Int J Gynecol Cancer.
2012;22(8):1407–12.
19. McCree-Hale R, Hale TM, Rutley KR, Aung M, Jolly PE. Evaluating a theory-based
health education intervention to improve awareness of prostate cancer among
men in Western Jamaica. West Indian Med J. 2012;61(6):580–6.
20. Siddique I, Mitchell DA. The impact of a community-based health education
programme on oral cancer risk factor awareness among a Gujarati
community. Br Dent J. 2013;215(4):E7.
21. Alidosti M, Sharifirad GR, Golshiri P, Azadbakht L, Hasanzadeh A, Hemati Z.
An investigation on the effect of gastric cancer education based on Health
Belief Model on knowledge, attitude and nutritional practice of housewives.
Iran J Nurs Midwifery Res. 2012;17(4):256–62.
22. Pentenero M, Chiecchio A, Gandolfo S. Impact of academic and continuing
education on oral cancer knowledge, attitude and practice among dentists
in north-western Italy. J Cancer Educ. 2014;29(1):151–7.
23. Ueland AS, Hornung PA, Greenwald B. Colorectal cancer prevention and
screening: a Health Belief Model-based research study to increase disease
awareness. Gastroenterol Nurs. 2006;29(5):357–63.
24. Sheinfeld Gorin S, Gemson D, Ashford A, Bloch S, Lantigua R, Ahsan H, et al.
Cancer education among primary care physicians in an underserved
community. Am J Prev Med. 2000;19(1):53–8.
Chai et al. BMC Cancer  (2015) 15:233 Page 11 of 1125. Alexander NE, Ross J, Sumner W, Nease Jr RF, Littenberg B. The effect of an
educational intervention on the perceived risk of breast cancer. J Gen Intern
Med. 1996;11(2):92–7.
26. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States,
2012: A review of current American Cancer Society guidelines and current
issues in cancer screening. CA Cancer J Clin. 2012. doi:10.3322/caac.20143.
27. Gupta AK, Melton 3rd LJ, Petersen GM, Timmons LJ, Vege SS, Harmsen WS,
et al. Changing trends in the incidence, stage, survival, and screen-detection
of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol.
2005;3(2):150–8.
28. Shi JF. A cost-effectiveness analysis of China cervical cancer screening
protocol for rural farmers. PhD thesis. China union Medical University. 2009.
29. Hady HR, Sołdatow M, Lukaszewicz J, Luba M, Pierko J, Myśliwiec P, et al.
Surgical treatment of malignant and benign colorectal neoplasms based on
authors’ clinical data. Adv Clin Exp Med. 2013;22(2):219–27.
30. Kuo CH, Weng BC, Wu CC, Yang SF, Wu DC, Wang YC. Apigenin has
anti-atrophic gastritis and anti-gastric cancer progression effects in
Helicobacter pylori-infected Mongolian gerbils. J Ethnopharmacol.
2014;151(3):1031–9.
31. Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating
Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin
Gastroenterol. 2013;27(6):933–47.
32. Gao QY, Chen HM, Chen YX, Wang YC, Wang ZH, Tang JT, et al. Folic acid
prevents the initial occurrence of sporadic colorectal adenoma in Chinese
older than 50 years of age: a randomized clinical trial. Cancer Prev Res
(Phila). 2013;6(7):744–52.
33. Farrell GC, Chan HL, Yuen MF, Amarapurkar DN, Chutaputti A, Fan JG, et al.
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus
statements. J Gastroenterol Hepatol. 2010;25(4):657–63.
34. Liu Q, Lu TX. Nasopharyngeal caner trends and prevention strategies.
Proceedings of the 13th Annual Conference of China Science and
Technology Association: 21 September 2011. China Tianjin: China
Association for Science and Technology, Tianjin Municipal People's
Government; 2011.
35. Zhai LF. Effectiveness and implications of colorectal cancer screening in
urban communities. Chin Prim Health Care. 2012;26(9):34–5.
36. Wang YD, Qu LY, Guan LZ, Wang GQ, Wang R, Peng DY, et al. Colorectal
cancer screening in Beijing community: effectiveness and problems. Chin J
Prim Health Care. 2007;10(19):1586–8.
37. Yao KY, Ma WL, Ma XY. Management of community-based cancer prevention
and control. China Cancer. 2014;23(1):23–5.
38. Honein-Abouhaidar GN, Kastner M, Vuong V, Perrier L, Rabeneck L,
Tinmouth J, et al. Benefits and barriers to participation in colorectal cancer
screening: a protocol for a systematic review and synthesis of qualitative
studies. BMJ Open. 2014;4(2):e004508.
39. Cadman L, Ashdown-Barr L, Waller J, Szarewski A. Attitudes towards cytology
and human papillomavirus self-sample collection for cervical screening among
Hindu women in London, UK: a mixed methods study. J Fam Plann Reprod
Health Care. 2015;41(1):38–47.
40. Liss DT, Baker DW. Understanding current racial/ethnic disparities in
colorectal cancer screening in the United States: the contribution
of socioeconomic status and access to care. Am J Prev Med.
2014;46(3):228–36.
41. Ozanne EM, Howe R, Omer Z, Esserman LJ. Development of a personalized
decision aid for breast cancer risk reduction and management. BMC Med
Inform Decis Mak. 2014;14:4.
42. Zimmer Z, Kwong J. Socioeconomic status and health among older adults
in rural and urban China. J Aging Health. 2004;16(1):44–70.
43. Feng R, Li K, Cheng J, Xie S, Chai J, Wei P, et al. Toward integrated and
sustainable prevention against diabetes in rural China: study rationale and
protocol of eCROPS. BMC Endocr Disord. 2013;13(1):28.
44. O’Carroll Bantum E, Albright CL, White KK, Berenberg JL, Layi G, Ritter PL,
et al. Surviving and thriving with cancer using a web-based health behavior
change intervention: randomized controlled trial. J Med Internet Res.
2014;16(2):e54.
45. Klein WM, Bloch M, Hesse BW, McDonald PG, Nebeling L, O’Connell ME,
et al. Behavioral research in cancer prevention and control: alook to the
future. Am J Prev Med. 2014;46(3):303–11.
46. Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM, et al.
Effects of a telephone-delivered multiple health behavior change intervention(Can Change) on health and behavioral outcomes in survivors of colorectal
cancer: a randomized controlled trial. J Clin Oncol. 2013;31(18):2313–21.
47. Zhang WK. Control the spread of HIV/STI by incorporating prevention with
treatment. J Chin AIDS/STD Pre Cont. 1996;2(6):248–53.
48. Ministry of Health of the People’s Republic of China. China Health Statistic
Annual. Beijing: Peking Union Medical College Press; 2009.
49. Zhang Y, Zhu X. The analysis of human resource against chronic disease
prevention department of Langfang in 2010. China foreign medical
treatment. 2011;13:68.
50. Li NX, Ren XH, Tang M. Patients intention of visiting doctor and community
health service. J China Health Serv Manag. 2001;2:101–2.
51. Rena W, Bonnie G. DPP Lifestyle Change Program Manual of Operation.
Pittsburgh: University of Pittsburgh; 1996 [http://www.bsc.gwu.edu/dpp/
apndxe2.pdf]
52. Chen P, Chai J, Cheng J, Li K, Xie S, Liang H, et al. A smart web aid for
preventing diabetes in rural china: preliminary findings and lessons. J Med
Internet Res. 2014;16(4):e98.
53. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ,
et al. Consolidated Standards of Reporting Trials Group: CONSORT 2010
Explanation and Elaboration: Updated guidelines for reporting parallel
group randomised trials. J Clin Epidemiol. 2010;63(8):e1–37.
54. Norat T, Aune D, Chan D, Romaguera D. Fruits and vegetables: updating the
epidemiologic evidence for the WCRF/AICR lifestyle recommendations for
cancer prevention. Cancer Treat Res. 2014;159:35–50.
55. Vainio H, Weiderpass E. Fruit and vegetables in cancer prevention. Nutr
Cancer. 2006;54(1):111–42.
56. Cundill G, Cumming GS, Biggs D, Fabricius C. Soft Systems Thinking and
Social Learning for Adaptive Management. Conserv Biol. 2012;26(1):13–20.
57. Yi-pin ZHU, Miao YU, Fu-qiang YANG, Jiang-dong ZHOU, Jun YANG, Qi
ZHAO, et al. The feasibility of developing a syndromic surveillance system in
rural China: A case study of two counties in Jiangxi province (in Chinese).
Chin J Health Pol. 2013;6(4):60–5.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
